|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Acebutolol#Drug Interactions]] |
| {{Acebutolol}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Drug Interactions==
| |
| | |
| [[Catecholamine]]-depleting drugs, such as [[reserpine]], may have an additive effect when given with β-blocking agents. Patients treated with Sectral plus [[Catecholamine]] depletors should, therefore, be observed closely for evidence of marked [[bradycardia]] or [[hypotension]] which may present as [[vertigo]], [[syncope]]/[[presyncope]], or orthostatic changes in blood pressure without compensatory [[tachycardia]]. Exaggerated hypertensive responses have been reported from the combined use of β-adrenergic antagonists and α-adrenergic stimulants, including those contained in proprietary cold remedies and vasoconstrictive nasal drops. Patients receiving β-blockers should be warned of this potential hazard.
| |
| | |
| Blunting of the [[antihypertensive]] effect of beta-adrenoceptor blocking agents by nonsteroidal anti-inflammatory drugs has been reported.
| |
| | |
| No significant interactions with [[digoxin]], [[hydrochlorothiazide]], [[hydralazine]], [[sulfinpyrazone]], oral [[contraceptives]], [[tolbutamide]], or [[warfarin]] have been observed.
| |
| | |
| Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. Concomitant use can increase the risk of [[bradycardia]].
| |
| | |
| <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SECTRAL (ACEBUTOLOL HYDROCHLORIDE) CAPSULE [PROMIUS PHARMA, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7eee95bf-0452-4d6e-9712-33403768695a | publisher = | date = | accessdate = 3 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Beta blockers]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |